Literature DB >> 22865239

Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry.

Susanna Horner1, Kurt Niederkorn, Thomas Gattringer, Martin Furtner, Raffi Topakian, Wilfried Lang, Robert Maier, Andreas Gamillscheg, Franz Fazekas.   

Abstract

Paradoxical embolism due to a patent foramen ovale (PFO) is a possible cause of ischemic stroke, particularly in young cryptogenic stroke patients. In most cases, however, it is difficult to establish a firm etiological association and the debate about management is ongoing. The Austrian Paradoxical Cerebral Embolism Trial was designed as a prospective, national, multi-center, non-randomized registry to add further data on this topic before the completion of randomized controlled trials. Over 27 months 188 cryptogenic stroke/TIA patients ≤55 years were entered by 15 Austrian stroke units. Contrast transesophageal echocardiography demonstrated a cardiac right-to-left shunt (RLS) in 176 patients; a pulmonary RLS was assumed in 10, and 2 showed both. Ninety-seven (55 %) patients with cardiac RLS underwent interventional treatment, and this was more likely for patients with stroke as index event, a symptomatic infarction on MRI and a large size of PFO. Over 2 years, recurrences occurred at a rate of approximately 1.3 % for stroke and 4.3 % for TIA, and were especially frequent in patients with pulmonary RLS. When comparing outcomes in patients with cardiac RLS there was a trend for fewer recurrences with interventional management (closure: four TIA in four patients vs. medical: three strokes and seven TIA in nine patients; p = 0.066 for events, p = 0.085 for patients). The complication rate was 13.4, and 5.7 % had residual shunting. The possible causes for paradoxical embolism in young patients with cryptogenic stroke appear more variable than usually considered, and other causes than PFO should not be neglected. Interventional treatment of a cardiac RLS may offer a small benefit, but has to be weighed against possible complications and the problem of establishing causality.

Entities:  

Mesh:

Year:  2012        PMID: 22865239     DOI: 10.1007/s00415-012-6629-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography.

Authors:  M Jauss; E Zanette
Journal:  Cerebrovasc Dis       Date:  2000 Nov-Dec       Impact factor: 2.762

2.  Morphological and functional characteristics of patent foramen ovale and their embolic implications.

Authors:  S De Castro; D Cartoni; M Fiorelli; M Rasura; A Anzini; E M Zanette; M Beccia; C Colonnese; F Fedele; C Fieschi; N G Pandian
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

Review 3.  Closure of patent foramen ovale: technique, pitfalls, complications, and follow up.

Authors:  B Meier
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events.

Authors:  Marie-Luise Mono; Laura Geister; Aekaterini Galimanis; Simon Jung; Fabien Praz; Marcel Arnold; Urs Fischer; Stefan Wolff; Oliver Findling; Stephan Windecker; Andreas Wahl; Bernhard Meier; Heinrich P Mattle; Krassen Nedeltchev
Journal:  Stroke       Date:  2011-08-04       Impact factor: 7.914

5.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

6.  Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group.

Authors:  J Bogousslavsky; S Garazi; X Jeanrenaud; N Aebischer; G Van Melle
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

7.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

8.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

9.  Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection.

Authors:  E B Ringelstein; D W Droste; V L Babikian; D H Evans; D G Grosset; M Kaps; H S Markus; D Russell; M Siebler
Journal:  Stroke       Date:  1998-03       Impact factor: 7.914

10.  Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy.

Authors:  R I White; A Lynch-Nyhan; P Terry; P C Buescher; E J Farmlett; L Charnas; K Shuman; W Kim; M Kinnison; S E Mitchell
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

View more
  7 in total

Review 1.  Stroke: an update.

Authors:  José M Ferro; Catarina Fonseca
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

2.  PFO Closure for Cryptogenic Stroke: Review of New Data and Results.

Authors:  Shyam Rao; Cathy Sila
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-06

3.  Patent foramen ovale closure for patients with cryptogenic stroke: A systematic review and comprehensive meta-analysis of 5 randomized controlled trials and 14 observational studies.

Authors:  Xi Chen; Shi-Dong Chen; Yi Dong; Qiang Dong
Journal:  CNS Neurosci Ther       Date:  2018-05-27       Impact factor: 5.243

4.  Coagulation Factor XIII Val34Leu Polymorphism in the Prediction of Premature Cardiovascular Events-The Results of Two Meta-Analyses.

Authors:  Beata Sarecka-Hujar; Danuta Łoboda; Elżbieta Paradowska-Nowakowska; Krzysztof S Gołba
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

Review 5.  Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.

Authors:  Jessica M Peña; Jorge R Kizer
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

6.  Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.

Authors:  Xin-Lin Zhang; Li-Na Kang; Lian Wang; Biao Xu
Journal:  BMC Cardiovasc Disord       Date:  2018-03-02       Impact factor: 2.298

7.  Long-term efficacy after closure of patent foramen ovale for ischemic neurological events in young adults: A systematic review and meta-analysis.

Authors:  Liang Xu; Xuemei Pan; Chang Zhou; Jie Li; Fangyuan Wang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.